Tatjana Stankovic
Research Projects
Defining genomic, pharmacological and microenvironmental contexts in which to target a protein hydroxylase
Tatjana Stankovic, Mathew Coleman & Daniel Tennant
Cancer Research UK
1/10/20 → 30/09/24
Project: Research
Utilising a synthetic lethality approach to specifically target ATM deficient tumours
Tatjana Stankovic, Nick Davies & Grant Stewart
Cancer Research UK
1/09/20 → 31/08/24
Project: Research
Targeting DDR defects in CLL as a model disease
ASTRA ZENECA UK LIMITED
1/01/19 → 1/08/21
Project: Research
Polymerase theta as a potential therapeutic target in chronic lymphocytic leukaemia (CLL)
Artios Pharma Limited
28/08/18 → 31/12/20
Project: Industry
Assessment of combined chemotherapy and ATR inhibition in xenograft models of refactory chronic lymphocytic leukaemia (CLL)
Tatjana Stankovic & Dickens Pratt
Cancer Research UK
1/11/15 → 31/10/16
Project: Research
New approaches for tackling refractory CLL
Grant Stewart, Malcolm Taylor, Paul Moss & Tatjana Stankovic
BLOODWISE
1/01/15 → 31/12/19
Project: Research
Evaluation of Novel Therapeutic Approaches in Chronic Lymphocytic Leukaemia to Eradicate Resistant Subclones with DNA Damage Response Defects
BLOODWISE
5/08/14 → 4/08/17
Project: Research
Development of New Approaches to Chemotherapy for Retinoblastoma
Carmel McConville & Tatjana Stankovic
BIRMINGHAM CHILDRENS HOSPITAL RESEARCH FOUNDATION
20/01/14 → 14/02/15
Project: Research
The Mechanisms of Clonal Progression and New Therapeutic Approaches in B Cell Chronic Lymphocytic Leukaemia (CLL) with a DNA Damage Defect
Tatjana Stankovic, Paul Moss, Grant Stewart & Malcolm Taylor
BLOODWISE
1/01/12 → 31/12/14
Project: Research